Cargando…
Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors
The usual treatments for patients with non-small-cell lung cancer (NSCLC), such as advanced lung adenocarcinoma, are unspecific and aggressive, and include lung resection, radiotherapy and chemotherapy. Recently, treatment with monoclonal antibodies and biological inhibitors has emerged as an effect...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404364/ https://www.ncbi.nlm.nih.gov/pubmed/27831000 http://dx.doi.org/10.1080/21645515.2016.1249551 |